|generic name||brand name||drug class or drug category||general use|
|benzphetamine||Didrex||appetite suppressant||management of obesity|
|buprenorphine (oral)||Subutex||partial opioid agonist||to treat narcotic (opioid) dependence|
|buprenorphine (patch)||Butrans||partial opioid agonist||for the management of severe pain|
|buprenorphine/naloxone||Suboxone; Zubsolv||partial opioid agonist||to treat narcotic (opioid) dependence|
|codeine 30mg/acetaminophen||Tylenol #3||narcotic analgesic||mild to moderate pain|
|phendimetrazine||Bontril||appetite suppressant||management of obesity|
|sodium oxybate||Xyrem||central nervous system depressant||excessive daytime sleepiness and cataplexy in narcolepsy patients|
|testosterone||AndroGel; AndroDerm; Testim||sex hormone||to treat low testosterone levels in men|
Schedule III same as C-III|
--- substances in this schedule have a potential for abuse less than substances in schedules I or II and abuse may lead to moderate or low physical dependence or high psychological dependence.
--- a prescription for a Schedule III drug may not be filled or refilled more than six months after the date thereof or be refilled more than five times after the date of the prescription unless renewed by the practitioner.
--- prescriptions for Schedule III controlled substances may be written, oral or transmitted by fax.
--- federal law requires the patient's street address on Rx's for controlled substances.
--- partial refills of Schedule III controlled substance prescriptions are permissible under federal regulations provided that each partial filling is dispensed and recorded in the same manner as a refilling (i.e., date refilled, amount dispensed, initials of dispensing pharmacist, etc...), the total quantity dispensed in all partial fillings does not exceed the total quantity prescribed and no dispensing occurs after six months past the date of issue.
--- for C-III drugs, the auxiliary label "Transfer Warning" is required.
--- labels for C-III drugs must show the date of initial filling.
--- labels for C-III drugs should contain the statement: "Caution: Federal law prohibits the transfer of this drug to any person other than the person for whom it was prescribed."